Evidence map›Paper›PMID 20660299›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2010

Human chorionic gonadotropin stimulates theca-interstitial cell proliferation and cell cycle regulatory proteins by a cAMP-dependent activation of AKT/mTORC1 signaling pathway.

Murugesan Palaniappan, K M J Menon

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Human Chorionic Gonadotropin and Early Embryogenesis: Review.International journal of molecular sciences · 2022
    Review
  5. Article
  6. Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?International journal of molecular sciences · 2021
    Review
  7. Review
  8. Review
  9. Article
  10. Role of mTOR Signaling in Female Reproduction.Frontiers in endocrinology · 2019
    Review
  11. Article
  12. Article
  13. The Role of Foxo3 in Leydig Cells.Yonsei medical journal · 2015
    Article
  14. Article
  15. Article
  16. CGB activates ERK and AKT kinases in cancer cells via LHCGR-independent mechanism.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Murugesan PalaniappanDepartment of Obstetrics, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
K M J Menon
University of Michigan–Ann Arbor · US

Funding

OVARIAN ANDROGEN PRODUCTION AND FOLLICULAR FUNCTIONR01HD038424 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MENON, JAIRAM K.M. · 2000 to 2010
$2.7M
NICHD NIH HHS HD 38424NICHD NIH HHS R01 HD038424
6 · The paper itself

Abstract

In addition to playing a cardinal role in androgen production, LH also regulates growth and proliferation of theca-interstitial (T-I) cells. Here, we show for the first time that LH/human chorionic gonadotropin (hCG) regulates T-I cell proliferation via the mammalian target of rapamycin complex 1 (mTORC1) signaling network. LH/hCG treatment showed a time-dependent stimulation of T-I cell proliferation and phosphorylation of protein kinase B (AKT), ERK1/2, and ribosomal protein (rp)S6 kinase 1 (S6K1), and its downstream effector, rpS6. Pharmacological inhibition of ERK1/2 signaling did not block the hCG-induced phosphorylation of tuberin, the upstream regulator of mTORC1 or S6K1, the downstream target of mTORC1. However, inhibition of AKT signaling completely blocked the hCG response. Furthermore, the AKT-specific inhibitor abolished forskolin (FSK)-stimulated phosphorylation of AKT, tuberin, S6K1, and rpS6. Human CG and FSK-mediated phosphorylation of AKT and downstream targets of mTORC1 were attenuated by inhibition of adenylyl cyclase. Pharmacologic targeting of mTORC1 with rapamycin also abrogated hCG or FSK-induced phosphorylation of S6K1, rpS6, and eukaryotic initiation factor 4E binding protein 1. In addition, hCG or FSK-mediated up-regulation of the cell cycle regulatory proteins cyclin-dependent kinase 4, cyclin D3, and proliferating cell nuclear antigen was blocked by rapamycin. These results were further confirmed by demonstrating that knockdown of mTORC1 using small interfering RNA abolished hCG-mediated increases in cell proliferation and the expression of cyclin D3 and proliferating cell nuclear antigen. Taken together, the present studies show a novel intracellular signaling pathway for T-I cell proliferation involving LH/hCG-mediated activation of the AKT/mTORC1 signaling cascade.

Indexed as

AnimalsCarrier ProteinsCell Cycle ProteinsCell ProliferationChorionic GonadotropinCyclic AMPCyclin D1Cyclin D3Enzyme ActivationFemaleGene Expression RegulationGene SilencingHumansIntracellular Signaling Peptides and ProteinsPhosphatidylinositol 3-KinasesPhosphoproteinsCarrier ProteinsCell Cycle ProteinsChorionic GonadotropinCrtc1 protein, ratCyclic AMPCyclin D1Cyclin D3Eif4ebp1 protein, ratIntracellular Signaling Peptides and ProteinsPhosphatidylinositol 3-KinasesPhosphoproteinsProto-Oncogene Proteins c-aktRibosomal Protein S6ribosomal protein S6 kinase, 70kD, polypeptide 1Ribosomal Protein S6 Kinases, 70-kDaRNA, MessengerRNA, Small InterferingSirolimusTranscription FactorsTSC2 protein, humanTuberous Sclerosis Complex 2 ProteinTumor Suppressor Proteins

Identifiers

PMID20660299
PMCPMC2940479
OpenAlexW2103985064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.